Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2018 Oct;19(5):165-171.
doi: 10.1080/15284336.2018.1513711. Epub 2018 Oct 27.

Maximizing participant retention in a phase 2B HIV prevention trial in Kampala, Uganda: The MTN-003 (VOICE) Study

Affiliations
Clinical Trial

Maximizing participant retention in a phase 2B HIV prevention trial in Kampala, Uganda: The MTN-003 (VOICE) Study

Joshua Wynne et al. HIV Clin Trials. 2018 Oct.

Abstract

Background: The success of longitudinal trials depends greatly on using effective strategies to retain participants and ensure internal validity, maintain sufficient statistical power, and provide for the generalizability of study results.

Objective: This paper describes the challenges and specific strategies used to retain participants in a Phase 2B safety and effectiveness study of daily oral and vaginal tenofovir formulations for the prevention of HIV-1 infection in the MTN-003 (VOICE) trial in Kampala, Uganda.

Methods: Once enrolled, participants were seen every 28 days at the research site and their study product was re-filled. Challenges to retention included a mobile population, non-disclosure of study participation to spouse/family, and economic constraints. Strategies used to maintain high participation rates included the use of detailed locator information, a participant tracking database, regular HIV/STI testing, and the formation of close bonds between staff and subjects.

Results: We enrolled 322 women out of the 637 screened. The overall retention rate was 95% over a 3 year follow up period. Only 179 (3%) out of the 6124 expected visits were missed throughout study implementation. Reasons for missed visits included: participants thinking that they did not need frequent visits due to their HIV negative status, time constraints due to commercial sex work, and migration for better employment.

Conclusions: With the implementation of multi-faceted comprehensive follow-up and retention strategies, we achieved very high retention rates in the MTN-003 study. This paper provides a blueprint for effective participant retention strategies for other longitudinal HIV prevention studies in resource-limited settings in Sub-Saharan Africa.

Keywords: HIV; PrEP; Sub-Saharan Africa; Uganda; clinical trials; prevention; retention.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Expected versus actual number of women seen at MU-JHU site by visit month.
Figure 2
Figure 2
Reasons for loss to follow-up.

References

    1. CDC. HIV Risk and Prevention: Pre-Exposure Prophylaxis (PrEP) [Internet] . CDC HIV/AIDS. Centers for Disease Control and Prevention; 2016. https://www.cdc.gov/hiv/risk/prep/. Accessed March 17, 2017.
    1. Marrazzo JM, Ramjee G, Richardson BA, et al. Tenofovir-based preexposure prophylaxis for HIV infection among African Women. N Engl J Med. 2015;372(6):509–518. - PMC - PubMed
    1. MTN-003 Description [Internet]. Microbicide Trials Network. http://www.mtnstopshiv.org/studies/70. Accessed March 10, 2017.
    1. Onoya D, Sifunda S, Wingood GM, van den Borne B, Ruiter RAC. Barriers to recruitment and retention of HIV-negative Black South African women into behavioral HIV prevention programs. J HIV/AIDS Soc Services. 2011;10(3):248–264.
    1. Beverley Cummings MM, Negashb W, Bekelec A, Ghileb T. Barriers to and facilitators for female participation in an HIV prevention project in Rural Ethiopia: findings from a qualitative evaluation. Cult Health Sex. 2006;8(3):251–266. - PubMed

Publication types

MeSH terms

Substances